Social Media

A pioneering cancer treatment has been recommended for leukaemia patients under the age of 25.CART-cell therapy involves taking a person's own immune cells and modifying them to fight their cancer cells, and has the potential to be a cure.The National Institute for Health and Care Excellence (Nice) said young people…
A medicine which helps to improve the quality of life for patients with an aggressive form of leukaemia is one of four drugs approved for use by the NHS in Scotland. The Scottish Medicines Consortium (SMC) has accepted Gemtuzumab ozogamicin, also known as Mylotarg, for the treatment of acute myeloid…
Children and young people with a form of leukaemia will have access to a groundbreaking treatment after NHS England secured a deal with the drug manufacturer. Tisagenlecleucel, a form of chimeric antigen receptor T-Cell (CAR-T) therapy, has been shown to cure some patients with B cell acute lymphoblastic leukaemia. NHS…
Olympic athlete Dame Kelly Holmes has described the "heartbreaking" experience of losing her mother to blood cancer as she campaigns to raise awareness of the disease. The double gold medal winner spoke out as it emerged that more than half of British adults could not name any symptoms of the…
More than half of British adults cannot name any symptom of blood cancer despite it being one of the most commonly diagnosed cancers in the UK, a charity has warned. Bloodwise said it found just 1% of people questioned said they were "very confident" they could identify common symptoms, even…
Children with cancer are having to travel twice as far and spend twice as much on journeys for treatment than adults, research has revealed. Children's cancer charity CLIC Sargent found young cancer patients and their families face average travel costs of £180 a month for their "cancer commute" of getting…
Researchers have been awarded £3.1 million for a pioneering study to help find new treatments for a rare form of blood cancer. Scientists at the University of Glasgow's Institute of Cancer Sciences will carry out laboratory experiments in tandem with a clinical trial to monitor how cancer cells in patients…
A drug that reduces the chances of relapse for people with an aggressive type of leukaemia is to be made available in Scotland. The Scottish Medicines Consortium (SMC) announced on Monday that doctors can use midostaurin – known by its brand name Rydapt – to treat patients with acute myeloid…
Patients from less affluent backgrounds have a greater chance of dying from a form of chronic blood cancer than those from more affluent areas, according to a comprehensive study carried out by researchers at the University of York. For the 500 people diagnosed with chronic myeloid leukaemia (CML) each year…